Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 12/2012

01.12.2012 | Review Article

The Impact of Internal or External Transanastomotic Pancreatic Duct Stents Following Pancreaticojejunostomy. Which One Is Better? A Meta-analysis

verfasst von: Yu Zhou, Quanbo Zhou, Zhihua Li, Qing Lin, Yuanfeng Gong, Rufu Chen

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The use of pancreatic duct stent to improve postoperative outcomes of pancreatic anastomosis remains a matter of debate, and the value of stenting when performing anastomosis for normal pancreas (soft and duct less than 3 mm) needs further study. The aim of the present meta-analysis was to evaluate the perioperative outcomes of patients with stenting during pancreatic anastomosis and compare the effect of external stent with that of internal stent indirectly.

Methods

A systematic literature search (EMBASE, MEDLINE, PubMed, The Cochrane Library, and Web of Science) was performed to identify studies evaluating external stent or internal stent. Included literature was assessed and extracted by two independent reviewers. A meta-analysis including comparative studies providing data on patients with and without external stenting or internal stenting during pancreaticojejunostomy anastomosis was performed.

Results

Thirteen articles including 1,867 patients were identified for inclusion: five randomized controlled trials study and eight observational clinical studies. Meta-analyses revealed that use of external stent was associated with a significantly decreased risk for pancreatic fistula in total (odds ratio (OR) 0.47; 95 % confidence interval (CI) 0.31–0.71; P = 0.0004; I 2 = 3 %), pancreatic fistula in normal pancreas(OR 0.5; 95 % CI 0.30–0.82; P = 0.007; I 2 = 5 %), and overall morbidity(OR 0.64; 95 % CI 0.45–0.90; P = 0.01; I 2 = 0 %); however, the meta-analysis showed that there were no significant differences between internal stenting and non-stenting groups as regards perioperative outcomes and that in fact it may increase pancreatic fistula rate in normal pancreas(OR 1.97; 95 % CI 1.05–3.69; P = 0.03; I 2 = 0 %).

Conclusions

The results of this analysis demonstrate a trend toward reduced pancreatic fistula with the use of external pancreatic stents in pancreaticojejunostomy. An internal stent does not impact development of fistula and that in fact it was not useful in a soft pancreas. Our conclusion may be limited to stenting during the duct-to-mucosa pancreaticojejunostomy anastomosis, and the value of stenting during invagination anastomosis needs further study.
Literatur
1.
Zurück zum Zitat Fernandez-delCastillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg. 1995;130: 295–300.PubMedCrossRef Fernandez-delCastillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg. 1995;130: 295–300.PubMedCrossRef
2.
Zurück zum Zitat Lieberman MD, Kilburn H, Lindsey M, et al. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222: 638–645.PubMedCrossRef Lieberman MD, Kilburn H, Lindsey M, et al. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222: 638–645.PubMedCrossRef
3.
Zurück zum Zitat Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg. 1997;226: 248–260.PubMedCrossRef Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg. 1997;226: 248–260.PubMedCrossRef
4.
Zurück zum Zitat Gouma DJ, Geenen RC, Gulik TM et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of the hospital volume. Ann Surg. 2000; 232(6): 786–795.PubMedCrossRef Gouma DJ, Geenen RC, Gulik TM et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of the hospital volume. Ann Surg. 2000; 232(6): 786–795.PubMedCrossRef
5.
Zurück zum Zitat Buechler MW, Friess H, Wagner M, et al. Pancreatic fistula after pancreatic head resection. Br J Surg. 2000;87: 883–889.CrossRef Buechler MW, Friess H, Wagner M, et al. Pancreatic fistula after pancreatic head resection. Br J Surg. 2000;87: 883–889.CrossRef
6.
Zurück zum Zitat Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011;364: 2128–2137PubMedCrossRef Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011;364: 2128–2137PubMedCrossRef
7.
Zurück zum Zitat Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998; 280: 1747–1751.PubMedCrossRef Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998; 280: 1747–1751.PubMedCrossRef
8.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, et al. International Study Group on Pancreatic Fistula. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138: 8–13.PubMedCrossRef Bassi C, Dervenis C, Butturini G, et al. International Study Group on Pancreatic Fistula. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138: 8–13.PubMedCrossRef
9.
Zurück zum Zitat Hashimoto Y, Traverso LW. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a Web-based calculator to improve homogeneity of definition. Surgery. 2010;147(4):503–515.PubMedCrossRef Hashimoto Y, Traverso LW. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a Web-based calculator to improve homogeneity of definition. Surgery. 2010;147(4):503–515.PubMedCrossRef
10.
Zurück zum Zitat Poon RT, Lo SH, Fong D, et al. Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy. Am J Surg. 2002;183: 42–52.PubMedCrossRef Poon RT, Lo SH, Fong D, et al. Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy. Am J Surg. 2002;183: 42–52.PubMedCrossRef
11.
Zurück zum Zitat Hosotani R, Doi R, Imamura M: Duct-to-mucosa pancreaticojejunostomy reduces the risk of pancreatic leakage after pancreatoduodenectomy. World J Surg. 2002;26:99–104.PubMedCrossRef Hosotani R, Doi R, Imamura M: Duct-to-mucosa pancreaticojejunostomy reduces the risk of pancreatic leakage after pancreatoduodenectomy. World J Surg. 2002;26:99–104.PubMedCrossRef
12.
Zurück zum Zitat Takeuchi K, Tsuzuki Y, Ando T, et al. Distal pancreatectomy: is staple closure beneficial? ANZ J Surg. 2003;73: 922–925.PubMedCrossRef Takeuchi K, Tsuzuki Y, Ando T, et al. Distal pancreatectomy: is staple closure beneficial? ANZ J Surg. 2003;73: 922–925.PubMedCrossRef
13.
Zurück zum Zitat Suc B, Msika S, Fingerhut A, et al; French Associations for Surgical Research. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of complications after pancreatic resection: prospective randomized trial. Ann Surg. 2003;237: 57–65. Suc B, Msika S, Fingerhut A, et al; French Associations for Surgical Research. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of complications after pancreatic resection: prospective randomized trial. Ann Surg. 2003;237: 57–65.
14.
Zurück zum Zitat Kapoor VK, Sharma A, Behari A, et al. Omental flaps in pancreaticoduodenectomy. JOP. 2006;7: 608–615.PubMed Kapoor VK, Sharma A, Behari A, et al. Omental flaps in pancreaticoduodenectomy. JOP. 2006;7: 608–615.PubMed
15.
Zurück zum Zitat Kawai M, Tani M, Terasawa H, et al: Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg. 2006;244: 1–7.PubMedCrossRef Kawai M, Tani M, Terasawa H, et al: Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg. 2006;244: 1–7.PubMedCrossRef
16.
Zurück zum Zitat Peng SY, Mou YP, Liu YB, et al. Binding pancreaticojejunostomy: 150 consecutive cases without leakage. J Gastrointest Surg. 2003;7(7): 898–900.PubMedCrossRef Peng SY, Mou YP, Liu YB, et al. Binding pancreaticojejunostomy: 150 consecutive cases without leakage. J Gastrointest Surg. 2003;7(7): 898–900.PubMedCrossRef
17.
Zurück zum Zitat Buc E, Flamein R, Golffier C, et al. Peng’s binding pancreaticojejunostomy after pancreaticoduodenectomy: a French prospective study. J Gastrointest Surg. 2010;14(4): 705–10.PubMedCrossRef Buc E, Flamein R, Golffier C, et al. Peng’s binding pancreaticojejunostomy after pancreaticoduodenectomy: a French prospective study. J Gastrointest Surg. 2010;14(4): 705–10.PubMedCrossRef
18.
Zurück zum Zitat Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282(11): 1054–1060.PubMedCrossRef Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282(11): 1054–1060.PubMedCrossRef
19.
Zurück zum Zitat Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. (Updated September, 2009). The Cochrane Collaboration; 2009. Available at: http://www.cochrane-handbook.org. Accessed October 2009. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. (Updated September, 2009). The Cochrane Collaboration; 2009. Available at: http://​www.​cochrane-handbook.​org. Accessed October 2009.
20.
Zurück zum Zitat Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328: 1490.PubMedCrossRef Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328: 1490.PubMedCrossRef
21.
Zurück zum Zitat Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336: 924–926.PubMedCrossRef Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336: 924–926.PubMedCrossRef
22.
Zurück zum Zitat Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138: 1714–1726.PubMedCrossRef Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138: 1714–1726.PubMedCrossRef
23.
Zurück zum Zitat Mollberg N, Rahbari NN, Koch M, et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011 Dec;254(6):882–93.PubMedCrossRef Mollberg N, Rahbari NN, Koch M, et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011 Dec;254(6):882–93.PubMedCrossRef
24.
Zurück zum Zitat Suc B, Msika S, Fingerhut A, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intraabdominal complications after pancreatic resection-prospective randomized trial. Ann. Surg. 2003;237: 57–65.PubMedCrossRef Suc B, Msika S, Fingerhut A, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intraabdominal complications after pancreatic resection-prospective randomized trial. Ann. Surg. 2003;237: 57–65.PubMedCrossRef
25.
Zurück zum Zitat Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327: 557–560.PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327: 557–560.PubMedCrossRef
26.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.PubMedCrossRef DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.PubMedCrossRef
27.
Zurück zum Zitat Egger M, DaveySmith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315: 629–634.PubMedCrossRef Egger M, DaveySmith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315: 629–634.PubMedCrossRef
28.
Zurück zum Zitat Shukla PJ, Barreto SG, Fingerhut A. Do transanastomotic pancreatic ductal stents after pancreatic resections improve outcomes? Pancreas. 2010;39(5): 561–566.PubMedCrossRef Shukla PJ, Barreto SG, Fingerhut A. Do transanastomotic pancreatic ductal stents after pancreatic resections improve outcomes? Pancreas. 2010;39(5): 561–566.PubMedCrossRef
29.
Zurück zum Zitat Poon RT, Fan ST. Decreasing the pancreatic leak rate after pancreaticoduodenectomy. Adv Surg. 2008;42: 33–48.PubMedCrossRef Poon RT, Fan ST. Decreasing the pancreatic leak rate after pancreaticoduodenectomy. Adv Surg. 2008;42: 33–48.PubMedCrossRef
30.
Zurück zum Zitat Zhou Y, Yang C, Wang S, et al. Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection?: a meta-analysis. Pancreatology. 2011;11(3):362–370.PubMedCrossRef Zhou Y, Yang C, Wang S, et al. Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection?: a meta-analysis. Pancreatology. 2011;11(3):362–370.PubMedCrossRef
32.
Zurück zum Zitat Winter JM, Cameron JL, Campbell KA, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2006;10(9):1280–90.PubMedCrossRef Winter JM, Cameron JL, Campbell KA, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2006;10(9):1280–90.PubMedCrossRef
33.
Zurück zum Zitat Lai EC, Chung NT, Yang GP, Li MK. Internal pancreatic ductal stenting to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a comparative study. Hepatogastroenterology. 2011;58(105): 163–7.PubMed Lai EC, Chung NT, Yang GP, Li MK. Internal pancreatic ductal stenting to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a comparative study. Hepatogastroenterology. 2011;58(105): 163–7.PubMed
34.
Zurück zum Zitat Smyrniotis V, Arkadopoulos N, Kyriazi MA, et al. Does internal stenting of the pancreaticojejunostomy improve outcomes after pancreatoduodenectomy? A prospective study. Langenbecks Arch Surg. 2010;395(3): 195–200.PubMedCrossRef Smyrniotis V, Arkadopoulos N, Kyriazi MA, et al. Does internal stenting of the pancreaticojejunostomy improve outcomes after pancreatoduodenectomy? A prospective study. Langenbecks Arch Surg. 2010;395(3): 195–200.PubMedCrossRef
35.
Zurück zum Zitat Suzuki S, Kaji S, Koike N, et al. Pancreaticojejunostomy of duct to mucosa anastomosis can be performed more safely without than with a stenting tube. Am J Surg. 2009;198(1): 51–4.PubMedCrossRef Suzuki S, Kaji S, Koike N, et al. Pancreaticojejunostomy of duct to mucosa anastomosis can be performed more safely without than with a stenting tube. Am J Surg. 2009;198(1): 51–4.PubMedCrossRef
36.
Zurück zum Zitat Mok KT, Wang BW, Liu SI. Management of pancreatic remnant with strategies according to the size of pancreatic duct after pancreaticoduodenectomy. Br J Surg. 1999;86(8):1018–9.PubMedCrossRef Mok KT, Wang BW, Liu SI. Management of pancreatic remnant with strategies according to the size of pancreatic duct after pancreaticoduodenectomy. Br J Surg. 1999;86(8):1018–9.PubMedCrossRef
37.
Zurück zum Zitat Grace PA, Pitt HA, Tompkins RK, et al. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg. 1986;151(1):141–149.PubMedCrossRef Grace PA, Pitt HA, Tompkins RK, et al. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg. 1986;151(1):141–149.PubMedCrossRef
38.
Zurück zum Zitat Moriya T, Clark CJ, Kirihara Y, et al. Stenting and the rate of pancreatic fistula following pancreaticoduodenectomy. Arch Surg. 2012 Jan;147(1): 35–40. Moriya T, Clark CJ, Kirihara Y, et al. Stenting and the rate of pancreatic fistula following pancreaticoduodenectomy. Arch Surg. 2012 Jan;147(1): 35–40.
39.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, et al. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 2007;246: 425–433.PubMedCrossRef Poon RT, Fan ST, Lo CM, et al. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 2007;246: 425–433.PubMedCrossRef
40.
Zurück zum Zitat Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg. 2011;253: 879–885.PubMedCrossRef Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg. 2011;253: 879–885.PubMedCrossRef
41.
Zurück zum Zitat Kuroki T, Tajima Y, Kitasato A, et al. Stenting versus non-stenting in pancreaticojejunostomy: a prospective study limited to a normal pancreas without fibrosis sorted by using dynamic MRI. Pancreas. 2011;40: 25–29.PubMedCrossRef Kuroki T, Tajima Y, Kitasato A, et al. Stenting versus non-stenting in pancreaticojejunostomy: a prospective study limited to a normal pancreas without fibrosis sorted by using dynamic MRI. Pancreas. 2011;40: 25–29.PubMedCrossRef
42.
Zurück zum Zitat Motoi F, Egawa S, Rikiyama T, et al. Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy. Br J Surg. 2012;99(4):524–531.PubMedCrossRef Motoi F, Egawa S, Rikiyama T, et al. Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy. Br J Surg. 2012;99(4):524–531.PubMedCrossRef
43.
Zurück zum Zitat Tani M, Onishi H, Kinoshita H, et al. The evaluation of duct-to-mucosal pancreaticojejunostomy in pancreaticoduodenectomy. World J Surg. 2005 Jan;29(1): 76–79. Tani M, Onishi H, Kinoshita H, et al. The evaluation of duct-to-mucosal pancreaticojejunostomy in pancreaticoduodenectomy. World J Surg. 2005 Jan;29(1): 76–79.
44.
Zurück zum Zitat Roder JD, Stein HJ, Böttcher KA, et al. Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg. 1999;229: 41–48.PubMedCrossRef Roder JD, Stein HJ, Böttcher KA, et al. Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg. 1999;229: 41–48.PubMedCrossRef
45.
Zurück zum Zitat Imaizumi T, Hatori T, Tobita K, et al. Pancreaticojejunostomy using duct-to-mucosa anastomosis without a stenting tube. J Hepatobiliary Pancreat Surg. 2006;13(3): 194–201.PubMedCrossRef Imaizumi T, Hatori T, Tobita K, et al. Pancreaticojejunostomy using duct-to-mucosa anastomosis without a stenting tube. J Hepatobiliary Pancreat Surg. 2006;13(3): 194–201.PubMedCrossRef
46.
Zurück zum Zitat Sriussadaporn S, Pak-Art R, Sriussadaporn S, et al. Pancreaticoduodenectomy with external drainage of the pancreatic remnant. Asian J Surg. 2008;31: 167–173.PubMedCrossRef Sriussadaporn S, Pak-Art R, Sriussadaporn S, et al. Pancreaticoduodenectomy with external drainage of the pancreatic remnant. Asian J Surg. 2008;31: 167–173.PubMedCrossRef
47.
Zurück zum Zitat Satoi S, Toyokawa H, Yanagimoto H, et al. Is a nonstented duct-to-mucosa anastomosis using the modified Kakita method a safe procedure? Pancreas. 2010;39: 165–170.PubMedCrossRef Satoi S, Toyokawa H, Yanagimoto H, et al. Is a nonstented duct-to-mucosa anastomosis using the modified Kakita method a safe procedure? Pancreas. 2010;39: 165–170.PubMedCrossRef
48.
Zurück zum Zitat Park JS, Hwang HK, Kim JK, et al. Clinical validation and risk factors for delayed gastric emptying based on the International Study Group of Pancreatic Surgery (ISGPS) Classification. Surgery. 2009;146; 882–887.PubMedCrossRef Park JS, Hwang HK, Kim JK, et al. Clinical validation and risk factors for delayed gastric emptying based on the International Study Group of Pancreatic Surgery (ISGPS) Classification. Surgery. 2009;146; 882–887.PubMedCrossRef
49.
Zurück zum Zitat Malleo G, Crippa S, Butturini G, et al. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: validation of International Study Group of Pancreatic Surgery classification and analysis of risk factors. HPB (Oxford). 2010; 12: 610–618.CrossRef Malleo G, Crippa S, Butturini G, et al. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: validation of International Study Group of Pancreatic Surgery classification and analysis of risk factors. HPB (Oxford). 2010; 12: 610–618.CrossRef
50.
Zurück zum Zitat Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232: 419–429.PubMedCrossRef Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232: 419–429.PubMedCrossRef
51.
Zurück zum Zitat Sato N, Yamaguchi K, Chijiiwa K, et al. Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg. 1998;133: 1094–1098.PubMedCrossRef Sato N, Yamaguchi K, Chijiiwa K, et al. Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg. 1998;133: 1094–1098.PubMedCrossRef
52.
Zurück zum Zitat Cheng Q, Zhang B, Zhang Y, et al. Predictive factors for complications after pancreaticoduodenectomy. J Surg Res. 2007;139: 22–29.PubMedCrossRef Cheng Q, Zhang B, Zhang Y, et al. Predictive factors for complications after pancreaticoduodenectomy. J Surg Res. 2007;139: 22–29.PubMedCrossRef
53.
Zurück zum Zitat Berger AC, Howard TJ, Kennedy EP, et al. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg 2009; 208: 738–747.PubMedCrossRef Berger AC, Howard TJ, Kennedy EP, et al. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg 2009; 208: 738–747.PubMedCrossRef
54.
Zurück zum Zitat Choe YM, Lee KY, Oh CA, et al. Risk factors affecting pancreatic fistulas after pancreaticoduodenectomy. World J Gastroenterol. 2008;14: 6970–6974.PubMedCrossRef Choe YM, Lee KY, Oh CA, et al. Risk factors affecting pancreatic fistulas after pancreaticoduodenectomy. World J Gastroenterol. 2008;14: 6970–6974.PubMedCrossRef
55.
Zurück zum Zitat Satoi S, Toyokawa H, Yanagimoto H, et al. A new guideline to reduce postoperative morbidity after pancreaticoduodenectomy. Pancreas. 2008;37: 128–133.PubMedCrossRef Satoi S, Toyokawa H, Yanagimoto H, et al. A new guideline to reduce postoperative morbidity after pancreaticoduodenectomy. Pancreas. 2008;37: 128–133.PubMedCrossRef
56.
Zurück zum Zitat Ohwada S, Tanahashi Y, Ogawa T, et al. In situ vs. ex situ pancreatic duct stents of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy with billroth I-type reconstruction. Arch Surg. 2002;137: 1289–1293.PubMedCrossRef Ohwada S, Tanahashi Y, Ogawa T, et al. In situ vs. ex situ pancreatic duct stents of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy with billroth I-type reconstruction. Arch Surg. 2002;137: 1289–1293.PubMedCrossRef
57.
Zurück zum Zitat Tani M, Kawai M, Hirono S et al. A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy. Am J Surg. 2010;199: 759–764.PubMedCrossRef Tani M, Kawai M, Hirono S et al. A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy. Am J Surg. 2010;199: 759–764.PubMedCrossRef
58.
Zurück zum Zitat Kamoda Y, Fujino Y, Matsumoto I, et al. Usefulness of performing a pancreaticojejunostomy with an internal stent after a pancreatoduodenectomy. Surg Today. 2008;38: 524–528.PubMedCrossRef Kamoda Y, Fujino Y, Matsumoto I, et al. Usefulness of performing a pancreaticojejunostomy with an internal stent after a pancreatoduodenectomy. Surg Today. 2008;38: 524–528.PubMedCrossRef
Metadaten
Titel
The Impact of Internal or External Transanastomotic Pancreatic Duct Stents Following Pancreaticojejunostomy. Which One Is Better? A Meta-analysis
verfasst von
Yu Zhou
Quanbo Zhou
Zhihua Li
Qing Lin
Yuanfeng Gong
Rufu Chen
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 12/2012
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-1987-2

Weitere Artikel der Ausgabe 12/2012

Journal of Gastrointestinal Surgery 12/2012 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.